<img alt="" src="https://secure.lazy8krti.com/218831.png" style="display:none;">

Case study: How we helped our client determine the global private market opportunity for a new vaccine

The challenge
Our client needed exploratory research to determine the global private market opportunity for a new vaccine for travelers to Sub Saharan Africa. It was crucial to determine: 

  • Which markets had the highest potential to purchase the vaccine in the private market, based on volume of travelers to appropriate regions and the nature of travel
  • Who the key stakeholders were in each market, in terms of involvement with travel vaccine recommendation, prescribing and purchasing
  • Receptivity to the vaccine in question
cs-private-market-opportunity-for-a-vaccine-for-travelers-to-sub-saharan-africa_242x266
cs-private-market-opportunity-for-a-vaccine-for-travelers-to-sub-saharan-africa_242x266

The challenge
Our client needed exploratory research to determine the global private market opportunity for a new vaccine for travelers to Sub Saharan Africa. It was crucial to determine: 

  • Which markets had the highest potential to purchase the vaccine in the private market, based on volume of travelers to appropriate regions and the nature of travel
  • Who the key stakeholders were in each market, in terms of involvement with travel vaccine recommendation, prescribing and purchasing
  • Receptivity to the vaccine in question

The solution
We conducted secondary desk research into travel behaviour and travel volumes to relevant regions, as well as identifying private vaccination providers in each country. We then initiated a first round of exploratory pilot interviews with a small number of participants in both North America and Europe and Sub Saharan African countries. This allowed us to understand the opportunity both in markets expected to have  high volumes of travel to regions affected by the vaccine-preventable disease, and markets in close proximity to those regions.

From this, we determined who the key players in vaccine decisions were, and which markets to best target for the full research sample. Once the full sample was agreed with our client, we proceeded to conduct interviews exploring the potential opportunity for the vaccine, in terms of who would be purchasing it. We also tested stakeholders’ reactions to a product profile of the vaccine in order to identify potential drivers and barriers to uptake. 

The outputs
Through our multiwave approach we were able to present our client with a clear account of the anticipated usage, impact on current practice and general expectations of product x. Our findings enabled us to share with our client a complete account of the barriers to uptake for their product, whilst sharing insightful ways to overcome the obstacles of the AKI market.

 

Sign up to receive Rapport

Rapport is our e-newsletter and online resource for sharing our expertise and experience in global healthcare market research.

Sign up here